PERFUSIONSMEDIUM

European patent · EP3673045 · In force

Register entry

Publication number
EP3673045
Application number
EP18786718
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 10, 2018
Published
Jul 1, 2020
Granted
Jan 17, 2024
Protection ends at the latest
Oct 9, 2038
Next annual fee due
Oct 31, 2026
IPC classes
C12N 5/00 (2006.01)
C12P 21/00 (2006.01)
Priority
US 201762571915 P 13.10.2017
PCT application
PCT/EP2018/077555 10.10.2018
PCT publication
WO2019/072889 18.04.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 27, 2024

    Change

    Published in Swissreg on 27.11.2024

  3. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  4. Jan 17, 2024

    Granted

    Published in Swissreg on 17.01.2024

Parties

Holder

Boehringer Ingelheim International GmbH

Binger Strasse 173, 55216 Ingelheim am Rhein, DE

Inventor

ZHENG, Lili

Fremont, CA 94555, US

LIN, Henry

Ridgefield CT 06877-0368, US

WANG, Samantha

Ridgefield CT 06877-0368, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.